Compare Atmos Energy Corporation (ATO) vs Charles River Laboratories Intl. Inc (CRL) Price & Performance

Atmos Energy (ATO) trades at $167.92, down 1.33% today, with a bearish technical signal despite recent earnings beats. The company reported Q3 2026 EPS of $1.43, beating estimates of $1.35, with revenue growth of 4.8% year-over-year. Strong profitability metrics include a 28.5% net income margin and 62.2% gross margin, while valuation ratios show a P/E of 20.2 and P/S of 5.7. Recent corporate developments include board appointments and dividend declarations of $1.00 per share.

ATO presents a mixed outlook with solid fundamentals and analyst support but faces technical headwinds. The consensus price target of $190.57 suggests 13.5% upside potential, supported by 45% buy ratings. Risks include high capital expenditures impacting cash flow and debt levels near $7.9 billion. Earnings growth and rate approvals provide catalysts, though the stock's bearish technical trend warrants caution near-term.

Charles River Laboratories (CRL) trades at $277.00, up 3.56% on the day and near its 52-week high of $277.07, reflecting strong bullish momentum. The stock exhibits positive technical signals with moving averages indicating an uptrend, though oscillators suggest overbought conditions. Fundamentally, the company reported Q2 2026 EPS of $3.02, beating estimates, and raised full-year guidance, yet faces profitability challenges with a negative net income margin of -5.96% and elevated valuation ratios like a P/E of 684.85. Recent news highlights improved biotech demand and institutional buying interest.

The outlook for CRL is cautiously optimistic, driven by earnings beats and raised guidance, but high valuation and weak profitability pose risks. Investment opportunity lies in sustained demand for drug development services, while risks include margin pressure, debt levels, and sensitivity to biotech funding cycles. The stock's proximity to all-time highs warrants monitoring for pullbacks.